This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (683) Breast Cancer (290) Clinical Information and Decision Making (1915) Clinical Cancer Research (116) Chemotherapy and Side Effects Management (110) Pathology and Laboratory Medicine (29)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56825, first published .
Assessing the Efficacy of Current Histopathological Tumor Reporting Systems for Evaluating the Response to Neoadjuvant Chemotherapy for Breast Carcinoma: Protocol for an Observational Study

Assessing the Efficacy of Current Histopathological Tumor Reporting Systems for Evaluating the Response to Neoadjuvant Chemotherapy for Breast Carcinoma: Protocol for an Observational Study

Assessing the Efficacy of Current Histopathological Tumor Reporting Systems for Evaluating the Response to Neoadjuvant Chemotherapy for Breast Carcinoma: Protocol for an Observational Study

Authors of this article:

Anita Sajjanar1 Author Orcid Image ;   Sunita Vagha2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Anita Sajjanar   1 * , MBBS, MD ;   Sunita Vagha   2 * , MBBS, MD

1 Department of Pathology, Datta Meghe Medical College, Shalinitai Meghe Hospital and Research Center, Nagpur, India

2 Jawaharlal Nehru Medical College, Sawangi, India

*all authors contributed equally

Corresponding Author:

  • Anita Sajjanar, MBBS, MD
  • Department of Pathology
  • Datta Meghe Medical College
  • Shalinitai Meghe Hospital and Research Center
  • Hingna Rd
  • Wanadongri
  • Nagpur 441110
  • India
  • Phone: 91 9886952097
  • Email: anitavijay28@gmail.com